ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

The Intersection of Immunology & Rheumatology

Mary Beth Nierengarten  |  November 5, 2025

The winning case study in this year’s Thieves Market highlight a case study from Malaysia with a patient who initially presented with seronegative inflammatory arthritis but experienced recurrent infections and had a porcelain aorta.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025Bruton’s diseaseX-linked Agammaglobulinemia

Incomplete Penetrance in Autoinflammatory Diseases

Michael Cammarata, MD, RhMSUS  |  November 1, 2025

At this ACR Convergence 2025 session, immunologist Dusan Bogunovic, PhD, discussed his team’s research into how genetic immune diseases manifest with different phenotypes in different people.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025geneticsinborn errors of immunitymonoallelic expressionResearch

Meeting Management Challenges in axSpA

Thomas R. Collins  |  November 1, 2025

At this ACR Convergence 2025 session, experts discussed emerging concepts with axial spondyloarthritis, including the most effective MRI specifications for diagnosis, challenges with axial juvenile spondyloarthritis & the many mimics of axSpA.

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting Reports Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAaxial juvenile spondyloarthritisaxial spondyloarthritis (SpA)

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 28, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on cutaneous manifestations of rheumatic diseases, gout, macrophage activation syndrome and vasculitis.

Filed under:ACR ConvergenceAmerican College of RheumatologyGout and Crystalline ArthritisMeeting ReportsOther Rheumatic ConditionsSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025GoutLupusmacrophage activation syndromeMethotrexatesystemic lupus erythematosus (SLE)Vasculitis

Let’s Discuss: Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 27, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on SLE and lupus nephritis, inflammatory brain diseases, drug management of rheumatic diseases and mimics of inflammatory myopathies.

Filed under:ACR ConvergenceMeeting ReportsOther Rheumatic ConditionsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNdrugInflammatory Brain DiseasesInflammatory MyopathiesLupusLupus nephritisRheumatic Diseasesystemic lupus erythematosus (SLE)

The 2025 ACR Awards of Distinction

Patrice Fusillo  |  October 25, 2025

The ACR honors excellence in rheumatology. Meet the 2025 Awards of Distinction recipients, ACR Masters & Distinguished Fellows recognized at ACR Convergence 2025.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2025ACR MastersDistinguished Clinical Investigatordistinguished fellowHenry Kunkel Young Investigator AwardhonorsPresidential Gold Medal

The ACR Names 16 New Masters

Patrice Fusillo  |  October 25, 2025

The ACR recognizes 16 members with its highest honor. See the 2025 class of ACR Masters & read their personal reflections on this career milestone.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2025Association of Rheumatology Professionals (ARP)

ACR Honors Distinguished Fellows: Class of 2025

Patrice Fusillo  |  October 25, 2025

Meet the 10 clinical & research fellows named 2025 ACR Distinguished Fellows. Learn what this prestigious honor means to them & their work.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2025Awardsdistinguished fellowFellowshonors

Rural Health Transformation Program: ACR Recommendations for Expanding Specialty Care Access

Joseph Cantrell, JD  |  October 19, 2025

The ACR has expert guidance for states applying for the Rural Health Transformation Program, including recommendations on policies designed to improve healthcare delivery, strengthen the workforce and ensure patient access to rheumatology care.

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Pediatric Rheumatologyrural rheumatologyWorkforce

What Rheumatologists Should Know About B Cell Tolerance & Autoimmunity

Katie Robinson  |  October 8, 2025

A recent Arthritis & Rheumatology review article explores the immune system’s mechanism for creating B cells that respond to diverse pathogens while preserving immune tolerance & highlights key insights for rheumatologists.

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Alport syndromeanti-GBM diseaseautoantibodiesautoreactive B cellsB cell toleranceB cellsGlomerulonephritiskidney diseaseneoantigensT-cells

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 112
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences